PAVmed Inc. beat EPS estimates 20% of the time across 20 reported quarters (4 beats, 16 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.66 | $-0.42 | +36.4% | Beat |
| Q12026 FY2026 | $-0.80 | $-4.47 | -458.8% | Miss |
| Q42025 FY2025 | $-4.80 | $-1.31 | +72.7% | Beat |
| Q12025 FY2025 | $-0.40 | $-0.06 | +85.0% | Beat |
| Q12024 FY2024 | $-1.89 | $-1.33 | +29.6% | Beat |
| Q3 FY2023 | $-0.14 | $-1.35 | -864.3% | Miss |
| Q2 FY2023 | $-0.19 | $-1.35 | -610.5% | Miss |
| Q1 FY2023 | $-0.21 | $-1.50 | -614.3% | Miss |
| Q12023 FY2023 | $-0.25 | $-2.25 | -800.0% | Miss |
| Q42022 FY2022 | $-0.26 | $-2.25 | -765.4% | Miss |
| Q32022 FY2022 | $-0.23 | $-2.55 | -1008.7% | Miss |
| Q22022 FY2022 | $-0.19 | $-2.10 | -1005.3% | Miss |
Back to PAVM overview · PAVM holders · PAVM KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.